Schizophrenia Trial, Recruiting NCT06236048 Sponsor: King's College London Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT06236048
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Healthy volunteers:

  • You have no history of any psychiatric (mental health) illness, as confirmed by a standard screening interview.

People with schizophrenia that responds to standard treatment:

  • You have been diagnosed with schizophrenia according to standard international guidelines (ICD-11).
  • Your symptoms are currently well-controlled (mild or minimal) and you have not had a significant return of symptoms in the past 6 months.
  • You are currently taking one of these medications: Olanzapine, Risperidone, Quetiapine, Amisulpride, Aripiprazole, or Paliperidone.
  • You are taking your antipsychotic medication regularly and consistently, as measured by a standard adherence scale.

People with schizophrenia that has not responded well to standard treatment:

  • You have been diagnosed with schizophrenia according to standard international guidelines (ICD-11).
  • You have tried at least two different antipsychotic medications in the past, each for at least 6 weeks at an adequate dose, without sufficient improvement.
  • Your current symptoms are rated as relatively severe on a standard symptom scale (confirm with trial site).
  • Your ability to function in daily life is moderately affected, as measured by a standard assessment scale (confirm with trial site).
  • You are currently taking one of these medications: Clozapine, Olanzapine, Risperidone, Quetiapine, Amisulpride, Aripiprazole, or Paliperidone.
  • You are taking your antipsychotic medication regularly and consistently, as measured by a standard adherence scale.

Who may not be able to join:

  • You are currently pregnant or breastfeeding.
  • You do not have the mental capacity to fully understand and agree to take part in the study.
  • You have diabetes or have previously taken diabetes medication.
  • You have a metal or electronic implant in your body, or dental wires, that are not safe for a very high-strength MRI scanner.
  • You have severe claustrophobia (fear of enclosed spaces) that would prevent you from having a PET or MRI scan.
  • Your body size is above the comfortable limits for the MRI scanner.
  • You have previously taken part in research or medical procedures involving radiation, and the total radiation exposure (including this study) would reach or exceed a certain safety level within the past 12 months (confirm with trial site).
  • You have had a head injury in the past that caused you to lose consciousness for more than 5 minutes.
  • You have a diagnosis of an organic brain disorder (a mental health condition caused by a physical condition affecting the brain).
  • You have a diagnosis of a mental health condition caused by substance use (such as alcohol or drugs).
  • You have a dependence on any substance other than nicotine or cannabis (confirm with trial site).
  • You have taken part in a clinical trial testing an unlicensed or experimental drug (other than a licensed antipsychotic) within the last month.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +442078480721

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 March 2024
Est. completion
31 December 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Brain glucose utilisation; Glutamate - anterior cingulate cortex; Lactate - visual cortex; Cerebral blood flow; Cortical network activity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov